Skip to main content
Springer logoLink to Springer
. 2016 Jul 11;27(8):2643–2646. doi: 10.1007/s00198-016-3699-z

Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation

C M Weaver 1, B Dawson-Hughes 2, J M Lappe 3,4, T C Wallace 5,6,7,
PMCID: PMC6828007  PMID: 27401092

Erratum to: Osteoporos Int

DOI: 10.1007/s00198-015-3386-5

Dear Editor,

In response to the communication from Drs. Bolland, Avenell, Grey, and Reid [1], we offer the following additional data and analyses. We apologize for several errors in Table 1 of the original publication [2]; the updated table is reproduced here (Table 1). We also offer the following method clarifications:

  • If studies reported multiple results, we used the data from participants who completed the studies (ie, per-protocol analysis).

  • Porthouse et al. stated: “In our unadjusted analysis we present the incidence of fracture by equally or unequally allocated groups as in any meta-analysis these need to be entered as two separate studies.” Therefore we treated these data as two studies since there was no overlapping in study participants among groups.

  • RRs were calculated using the original numbers of events and non-events in each group.

Table 1.

Summary of meta-analysis results for calcium plus vitamin D supplementation versus placebo and fracture risk

Study Status Subgroup Vitamin D (IU/day) Calcium (mg/day) Number of total fracture events/total Number of hip fracture events/total
Reported RR/HR (95 % CI) Calculated RR (95 % CI) Treatment Control Reported RR/HR (95 % CI) Calculated RR (95 % CI) Treatment Control
Chapuy et al, 1992 [3] Institutionalized 800 1200 ND

0.69

(0.51, 0.93)

66/877 97/888 ND

0.57

(0.34, 0.97)

21/877 37/888
Chapuy et al, 2002 [4] Institutionalized 800 1200 ND ND ND ND

Placebo vs. treatment 1.69

(0.96–3)

0.62

(0.36, 1.07)

27/393 21/190
Dawson-Hughes et al, 1997 [5] Community-dwelling 700 500

0.4

(0.2, 1.0)

0.37

(0.19, 0.72)

11/170 26/148 ND

0.29

(0.01, 7.08)

0/170 1/148
Porthouse et al, 2005 [6] Community-dwelling Unequally allocated group 800 1000 ND

0.96

(0.64, 1.43)

34/714 69/1391 ND

0.39

(0.11, 1.34)

3/714 15/1391
Porthouse et al, 2005 [6] Community-dwelling Equally allocated group 800 1000 ND

1.08

(0.61, 1.91)

24/607 22/602 ND

2.48

(0.48, 12.78)

5/607 2/602
Prentice et al, 2013 [7]a Community-dwelling 400 1000 ND

0.92

(0.80, 1.04)

405/7530b 458/7801b ND

0.53

(0.31, 0.93)

19/7530b 35/7406b
Salovaara et al, 2010 [8] Community-dwelling 800 1000

Adjusted HR 0.83

(0.61, 1.12)

0.84

(0.63, 1.13)

78/1586 94/1609

Adjusted HR 2.23

(0.41–12.29)

2.03

(0.37, 11.06)

4/1586 2/1609
Grant et al, 2015 [9]c Community-dwelling with history of fracture 800 1000 ND

0.95

(0.79, 1.15)

179/1306 192/1332 ND ND ND ND
Harwood et al, 2004 [10] Community-dwelling with history of fracture 800 1000 ND

0.72

(0.19, 2.78)

3/29 5/35 ND ND ND ND
Total (random model)

0.86

(0.75, 0.98)

800/12819 963/13806

0.61

(0.46, 0.82)

79/11877 113/12234

CI confidence interval, ND no data, RR relative risk, HR hazard ratio, WHI Women’s Health Initiative

aData analyzing the WHI for adherence to assigned pills and no personal use of supplements from Table 6 in Prentice et al. [7]

bData provided from WHI investigators

cThe results from data of fracture confirmed by radiography

After incorporating the above suggestions from Bolland et al., the overall RR (95 % CI) for total fractures changed from 0.85 (0.73–0.98) to 0.86 (0.75–0.98) (Fig. 1), and the overall RR (95 % CI) for hip fractures changed from 0.70 (0.56–0.87) to 0.61 (0.46–0.82) (Fig. 2). These alterations do not affect the original publication’s conclusions. These data could further suggest that calcium with vitamin D supplementation may have a greater impact on preventing hip fractures than originally described.

Fig. 1.

Fig. 1

Total fractures

Fig. 2.

Fig. 2

Hip fractures

We also apologize for a typographical error in the original text [2]. The dataset contains 192 hip fractures, as listed in the original publication’s table (not 195). Since the number of 192 hip fractures were used in the data analysis, this error did not affect the outcome of the study.

Acknowledgments

The authors would like to thank Dr. Mei Chung and Zhuxuan Fu for their help in running the additional meta-analyses provided here.

Funding

Funding sources for the original analyses (DOI: 10.1007/s00198-015-3386-5) were declared in the publication. The authors have not received additional funding or compensation for the new work reported here.

Compliance with ethical standards

Conflicts of interest

The authors declared all conflicts of interest in the original publication (DOI: 10.1007/s00198-015-3386-5).

Footnotes

The online version of the original article can be found at 10.1007/s00198-015-3386-5.

Contributor Information

C. M. Weaver, Email: weavercm@purdue.edu

B. Dawson-Hughes, Email: bess.dawson-hughes@tufts.edu

J. M. Lappe, Email: joanlappe@creighton.edu

T. C. Wallace, Phone: 270.839.1776, FAX: 703.414.3742, Email: taylor.wallace@me.com

References

  • 1.Bolland MJ, Avenell A, Grey A, Reid IR. Errors in NOF meta-analyses of calcium and vitamin D supplements. Osteoporos Int. 2016 doi: 10.1007/s00198-015-3466-6. [DOI] [PubMed] [Google Scholar]
  • 2.Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, Liu S, Looker AC, Wallace TC, Wang DD. Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27:367–376. doi: 10.1007/s00198-015-3386-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327:1637–1642. doi: 10.1056/NEJM199212033272305. [DOI] [PubMed] [Google Scholar]
  • 4.Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier PJ. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int. 2002;13:257–264. doi: 10.1007/s001980200023. [DOI] [PubMed] [Google Scholar]
  • 5.Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium with combined vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670–676. doi: 10.1056/NEJM199709043371003. [DOI] [PubMed] [Google Scholar]
  • 6.Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ. Randomised controlled trial of calcium supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005;330:1003. doi: 10.1136/bmj.330.7498.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24:567–580. doi: 10.1007/s00198-012-2224-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Salovaara K, Tuppurainen M, Kärkkäinen M, Rikkonen T, Sandini L, Sirola J, Honkanen R, Alhava E, Kröger H. Effect of vitamin D(3) and calcium on risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial – the OSTPRE-FPS. J Bone Miner Res. 2010;25:1487–1495. doi: 10.1002/jbmr.48. [DOI] [PubMed] [Google Scholar]
  • 9.Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA, RECORD Trial Group Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or Vitamin D, RECORD): a randomised placebo controlled trial. Lancet. 2005;365:1621–1628. doi: 10.1016/S0140-6736(05)63013-9. [DOI] [PubMed] [Google Scholar]
  • 10.Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ, Nottingham Neck of Femur (NONOF) Study A randomised, controlled comparison of different calcium with combined vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Aging. 2004;33:45–51. doi: 10.1093/ageing/afh002. [DOI] [PubMed] [Google Scholar]

Articles from Osteoporosis International are provided here courtesy of Springer

RESOURCES